Roberto Buzzoni

6.3k total citations
165 papers, 3.7k citations indexed

About

Roberto Buzzoni is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Roberto Buzzoni has authored 165 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Oncology, 64 papers in Epidemiology and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Roberto Buzzoni's work include Neuroendocrine Tumor Research Advances (60 papers), Lung Cancer Research Studies (41 papers) and Neuroblastoma Research and Treatments (26 papers). Roberto Buzzoni is often cited by papers focused on Neuroendocrine Tumor Research Advances (60 papers), Lung Cancer Research Studies (41 papers) and Neuroblastoma Research and Treatments (26 papers). Roberto Buzzoni collaborates with scholars based in Italy, United States and Switzerland. Roberto Buzzoni's co-authors include Emilio Bajetta, Luigi Mariani, Maria Di Bartolomeo, Nicoletta Zilembo, Luigi Celio, Gianni Bonadonna, Angelo Di Leo, Carlo Carnaghi, Sara Pusceddu and Pinuccia Valagussa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The American Journal of Medicine.

In The Last Decade

Roberto Buzzoni

161 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto Buzzoni Italy	33	2.5k	1.3k	937	678	474	165	3.7k
Richard G. Hahn United States	26	2.0k 0.8×	1.5k 1.1×	1.1k 1.2×	785 1.2×	653 1.4×	65	3.4k
Enrique Grande Spain	35	2.5k 1.0×	1.4k 1.1×	966 1.0×	1.2k 1.8×	831 1.8×	286	4.6k
Seena C. Aisner United States	30	1.8k 0.7×	1.8k 1.4×	864 0.9×	1.5k 2.2×	458 1.0×	100	4.4k
Nicoletta Zilembo Italy	29	2.1k 0.8×	807 0.6×	488 0.5×	969 1.4×	190 0.4×	113	3.2k
Antonia Martinetti Italy	32	1.5k 0.6×	837 0.6×	618 0.7×	618 0.9×	278 0.6×	121	2.8k
Lori A. Erickson United States	40	2.3k 0.9×	992 0.7×	386 0.4×	587 0.9×	1.1k 2.4×	185	5.5k
Felice Pasini Italy	35	1.6k 0.6×	544 0.4×	437 0.5×	1.5k 2.2×	703 1.5×	119	3.5k
Sigurd Lax Austria	39	2.1k 0.8×	804 0.6×	378 0.4×	867 1.3×	646 1.4×	145	5.9k
Naris Nilubol United States	35	1.3k 0.5×	1.3k 1.0×	758 0.8×	297 0.4×	1.2k 2.6×	162	4.0k
Roberto Franchi Italy	25	987 0.4×	545 0.4×	471 0.5×	637 0.9×	217 0.5×	68	2.4k

Countries citing papers authored by Roberto Buzzoni

Since Specialization

Citations

This map shows the geographic impact of Roberto Buzzoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Buzzoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Buzzoni more than expected).

Fields of papers citing papers by Roberto Buzzoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Buzzoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Buzzoni. The network helps show where Roberto Buzzoni may publish in the future.

Co-authorship network of co-authors of Roberto Buzzoni

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Buzzoni. A scholar is included among the top collaborators of Roberto Buzzoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Buzzoni. Roberto Buzzoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fazio, Nicola, Carlo Carnaghi, Roberto Buzzoni, et al.. (2021). Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT‐3 and RADIANT‐4 trials. Cancer. 127(15). 2674–2682. 5 indexed citations

Yao, James C., Nicola Fazio, Roberto Buzzoni, et al.. (2016). ORAL02.02: Efficacy and Safety of Everolimus in Advanced, Progressive, Nonfunctional Neuroendocrine Tumors (NET) of the Lung: RADIANT-4 Subgroup Analysis. Journal of Thoracic Oncology. 11(11). S253–S253. 2 indexed citations

Pusceddu, Sara, Giuseppe Lo Russo, Silvia Ortolani, et al.. (2016). Update on medical treatment of small intestinal neuroendocrine tumors. Expert Review of Anticancer Therapy. 16(9). 969–976. 4 indexed citations

Cortinovis, Diego, Giordano Beretta, Elena Piazza, et al.. (2013). Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based survey.. PubMed. 99(1). 45–50. 11 indexed citations

Seregni, Ettore, Marco Maccauro, Claudio Chiesa, et al.. (2013). Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy. European Journal of Nuclear Medicine and Molecular Imaging. 41(2). 223–230. 75 indexed citations

Buzzoni, Roberto, Sara Pusceddu, Angela Damato, et al.. (2013). Malignant pheochromocytoma and paraganglioma: future considerations for therapy.. PubMed. 57(2). 153–60. 8 indexed citations

Cortinovis, Diego, Giordano Beretta, Elena Piazza, et al.. (2013). Chemotherapy-Induced Anemia and Oncologist Perception on Treatment: Results of a Web-Based Survey. Tumori Journal. 99(1). 45–50. 11 indexed citations

Pusceddu, Sara, Emilio Bajetta, Roberto Buzzoni, et al.. (2008). Primary Uterine Cervix Melanoma Resembling Malignant Peripheral Nerve Sheath Tumor: A Case Report. International Journal of Gynecological Pathology. 27(4). 596–600. 13 indexed citations

Bajetta, Emilio, Marco Platania, Laura Catena, et al.. (2007). MERKEL CELL CARCINOMAAFTER LIVER TRANSPLANTATION: A CASE REPORT. Tumori. 97(3). 323–326. 1 indexed citations

10.

Bartolomeo, Maria Di, Roberto Buzzoni, Luigi Mariani, et al.. (2006). Feasibility of Sequential Therapy with FOLFIRI Followed by Docetaxel/Cisplatin in Patients with Radically Resected Gastric Adenocarcinoma. Oncology. 71(5-6). 341–346. 11 indexed citations

11.

Bajetta, Emilio, Maria Di Bartolomeo, Luigi Mariani, et al.. (2004). Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first‐line treatment in metastatic colorectal carcinoma. Cancer. 100(2). 279–287. 115 indexed citations

12.

Bajetta, E., Luigi Celio, Roberto Buzzoni, et al.. (2003). Phase II study of pemetrexed disodium (Alimta®) administered with oral folic acid in patients with advanced gastric cancer. Annals of Oncology. 14(10). 1543–1548. 49 indexed citations

13.

Bajetta, Emilio, Laura Biganzoli, Carlo Carnaghi, et al.. (1998). Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer. Cancer. 83(6). 1136–1141. 10 indexed citations

14.

Bozzetti, Federico, Laura Biganzoli, Cecilia Gavazzi, et al.. (1997). Glutamine supplementation in cancer patients receiving chemotherapy: A double-blind randomized study. Nutrition. 13(7-8). 748–751. 64 indexed citations

15.

Bajetta, Emilio, Nicoletta Zilembo, Sandro Barni, et al.. (1997). A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: Endocrine and clinical results. Annals of Oncology. 8(7). 649–654. 11 indexed citations

16.

Bajetta, Emilio, Marco Colleoni, Maria Di Bartolomeo, et al.. (1995). Doxifluridine and leucovorin: an oral treatment combination in advanced colorectal cancer.. Journal of Clinical Oncology. 13(10). 2613–2619. 37 indexed citations

17.

Leo, Angelo Di, Emilio Bajetta, Roberto Buzzoni, et al.. (1995). Epirubicin Plus Medroxyprogesterone as Second-Line Treatment of Advanced Prostatic Cancer. American Journal of Clinical Oncology. 18(3). 239–244. 4 indexed citations

18.

Bajetta, Emilio, Nicoletta Zilembo, Maria Di Bartolomeo, et al.. (1993). Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a: A study by the Italian trials in Medical Oncology Group. Cancer. 72(10). 3099–3105. 107 indexed citations

19.

Bajetta, Emilio, B. Giannotti, Laura Brogelli, et al.. (1990). Phase II Study of Interferon α-2a and Dacarbazine in Advanced Melanoma. American Journal of Clinical Oncology. 13(5). 405–409. 20 indexed citations

20.

Bajetta, Emilio, Roberto Buzzoni, Pinuccia Valagussa, & Gianni Bonadonna. (1988). Mitoxantrone. American Journal of Clinical Oncology. 11(2). 100–103. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact